Jefferies analyst Joseph Gallo lowered the firm’s price target on Varonis (VRNS) to $50 from $60 and keeps a Buy rating on the shares after the company “disappointingly” guided calendar year 2026 ARR to grow 10% year-over-year, missing consensus at 14%. While investor angst is focused on 10% year-over-year growth in 2026, the firm views this as a reset of expectations and sees a path to mid-to-high teens ARR growth in 2027, the analyst tells investors.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VRNS:
- Varonis price target lowered to $28 from $37 at Citi
- Varonis price target lowered to $40 from $57 at TD Cowen
- Varonis price target lowered to $38 from $45 at Barclays
- Varonis: SaaS Transition Nearing Maturity Drives Long-Term Growth and Attractive Risk-Reward, Justifying Buy Rating
- Balancing Robust SaaS Momentum with Migration Risk: Rationale for Maintaining a Hold on Varonis
